Hepatitis B surface antigen (HBsAg) prevalence in Cyprus
Cyprus: Hepatitis B surface antigen (HBsAg) prevalence was 0.5% in 2024. βΌ Falling
Latest (2024)
0.5%
Change on year
unchanged
World rank
59th
of 192 countries
All-time high
0.6%
in 2015
All-time low
0.5%
in 2020
Years of data
10
2015β2024
Hepatitis B surface antigen (HBsAg) prevalence in Cyprus, 2015β2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Cyprus is 0.5%, measured in 2024. That is the lowest value across all 10 years on record.
The figure is down 16.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Cyprus peaked at 0.6% in 2015 and was at its lowest, 0.5%, in 2020.
Cyprus ranks 59th of 192 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.6% | 5 |
| 2020s | 0.5% | 0.5% | 0.5% | 5 |
Countries ranked near Cyprus
- 59 Yemen 0.5% compare
- 59 Eritrea 0.5% compare
- 62 Senegal 0.4% compare
- 62 Tanzania, United Republic of 0.4% compare
- 62 Samoa 0.4% compare
- 62 Zambia 0.4% compare
- 62 Burundi 0.4% compare
- 62 Bangladesh 0.4% compare
- 62 Iraq 0.4% compare
- 62 Cambodia 0.4% compare
- 62 Korea, Democratic People's Republic of 0.4% compare
More health data for Cyprus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.51 % change on previous year (2090)
- Heat deaths vs projected death rates 1,325 (2090)
- Un projection of annual infant deaths 7 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 8,247 (2025)
- Age population, age 25, female, interpolated 7,986 (2025)
- Age population, age 24, male, interpolated 7,978 (2025)
- Age population, age 24, female, interpolated 7,707 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Cyprus?
- Hepatitis b surface antigen (hbsag) prevalence in Cyprus was 0.5% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Cyprus?
- The highest recorded value was 0.6% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Cyprus?
- The lowest recorded value was 0.5% in 2020.
- How does Cyprus rank for hepatitis b surface antigen (hbsag) prevalence?
- Cyprus ranks 59th out of 192 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Cyprus?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Cyprus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).